Animal Microbiome Analytics, Inc.

Animal Microbiome Analytics, Inc. focuses on improving pet health through innovative gut health solutions, addressing gastrointestinal issues in pets with specialized products and services. Founded in 2016 and headquartered in Oakland, US, Animal Microbiome Analytics, Inc. specializes in gut health solutions for pets.

The company's founder, Carlton Osborne, has a history of entrepreneurial ventures. In April 2022, the company raised USD 5. 5 mn in Series A funding from investor SOSV, bringing the total amount raised to USD 5. 5 mn.

AnimalBiome specializes in gut health solutions for pets, offering products like the Gut Restore Supplement, S. boulardii + FOS Powder, and microbiome testing services. These products aim to enhance the gut microbiome of cats and dogs, addressing issues such as diarrhea and skin problems linked to gastrointestinal imbalance. The company serves a diverse customer base across the United States, Canada, and Europe, providing accessible products to veterinarians and pet retailers.

AnimalBiome generates revenue through direct-to-consumer sales of its health products and microbiome testing services, primarily via its online platform. Customers can purchase items individually or through subscriptions, catering to various consumer needs with offerings designed to manage pet health, resulting in consistent sales from individual pet owners and veterinary professionals. Following the USD 5. 5 mn Series A funding raised in April 2022, Animal Microbiome Analytics, Inc.

plans to expand its product line to include new gut health solutions aimed at pets, targeting launch within the coming year. The company also intends to venture into new geographic markets, specifically aiming for broader access in Europe and Canada by the end of 2023. Recent funding will support these initiatives, enhancing their capacity to develop and market innovative products.